13F Holdings
中文EN

KIDS ORTHOPEDIATRICS CORP

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1425450 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY16.1%
TTM net income YoY25.7%
TTM EPS YoY27.6%
Revenue 3-yr CAGR23.0%
Net income 3-yr CAGR—

Margins

Gross margin73.8%
Operating margin-9.4%
Net margin-12.8%
FCF margin1.2%
EBITDA margin-0.8%

Returns

ROE-9.8%
ROA-6.8%
ROIC (approx.)-4.6%
Asset turnover0.53x

Leverage & solvency

Liabilities / assets33.3%
Debt / equity0.30x
Current ratio4.55x
Interest coverage-2.70x

Cash quality & payout

Operating cash flow / net income-0.37x
Accruals ratio-9.3%
Payout ratio—
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$236.35M$204.73M$148.73M$122.29M$98.05M
Cost of revenue$63.69M$56.13M$37.48M$31.63M$24.65M
Gross profit$172.66M$148.60M$111.25M$90.66M$73.40M
R&D expense$9.10M$11.03M$10.89M$8.45M$5.54M
SG&A expense$119.83M$102.79M$73.30M$57.90M$46.06M
Operating income-$39.24M-$35.01M-$26.75M-$25.40M-$18.02M
Interest expense$6.00M$2.62M-$198,000$2.42M$56,000
Pretax income-$39.19M-$41.93M-$21.31M-$3.69M-$17.39M
Income tax$460,000-$4.11M-$338,000-$4.95M-$1.13M
Net income-$39.65M-$37.82M-$20.97M$1.26M-$16.26M
EBITDA-$18.12M-$15.93M-$9.37M-$12.30M-$7.34M
EPS (basic)-1.69-1.64-0.920.06-0.84
EPS (diluted)-1.69-1.64-0.920.06-0.84
Weighted avg. shares (diluted)23.46M23.08M22.68M20.95M19.27M
Banking
Net interest income——$198,000-$2.42M-$2.25M
Balance sheet
Cash & equivalents$19.56M$45.78M$33.03M$10.46M$9.01M
Short-term investments$41.30M$25.01M$49.25M$109.30M$45.90M
Receivables$53.84M$42.36M$34.62M$24.80M$17.94M
Inventory$133.79M$117.00M$105.85M$78.19M$57.57M
Current assets$256.42M$237.17M$226.50M$226.72M$133.65M
PP&E, net$49.55M$50.60M$41.05M$34.29M$28.52M
Goodwill$109.27M$93.84M$83.70M$86.82M$72.35M
Intangibles$64.80M$64.43M$69.28M$64.98M$55.49M
Total assets$508.63M$473.21M$438.75M$427.73M$304.27M
Current liabilities$46.20M$33.96M$41.67M$30.87M$29.71M
Short-term debt$1.87M$897,000$152,000$144,000$137,000
Long-term debt$99.82M$72.96M$9.91M$763,000$907,000
Total debt$101.68M$73.85M$10.06M$907,000$1.04M
Total liabilities$162.03M$118.64M$61.72M$49.08M$78.91M
Shareholders' equity$346.60M$354.57M$377.02M$378.65M$225.37M
Net debt$82.13M$28.08M-$22.97M-$9.55M-$7.96M
Shares outstanding25.09M24.22M23.38M22.88M19.68M
Cash flow statement
Operating cash flow-$4.85M-$27.05M-$27.05M-$21.77M-$13.06M
Capital expenditure$11.11M$14.26M$16.88M$10.03M$8.10M
Free cash flow-$15.96M-$41.31M-$43.92M-$31.80M-$21.17M
Investing cash flow-$43.63M-$13.16M$41.68M-$113.37M-$7.41M
Financing cash flow$23.98M$53.13M$7.30M$135.97M$6,000
Depreciation & amortization$21.12M$19.08M$17.39M$13.10M$10.68M
Stock-based compensation$17.78M$13.55M$10.53M$6.68M$5.84M

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.